24.95
Azenta Inc stock is traded at $24.95, with a volume of 813.17K.
It is up +2.84% in the last 24 hours and up +16.48% over the past month.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
See More
Previous Close:
$24.26
Open:
$24.39
24h Volume:
813.17K
Relative Volume:
0.91
Market Cap:
$1.15B
Revenue:
$595.19M
Net Income/Loss:
$28.96M
P/E Ratio:
-19.68
EPS:
-1.2679
Net Cash Flow:
$30.93M
1W Performance:
+11.88%
1M Performance:
+16.48%
6M Performance:
-22.15%
1Y Performance:
-3.71%
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AZTA
Azenta Inc
|
24.95 | 1.12B | 595.19M | 28.96M | 30.93M | -1.2679 |
|
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-25 | Reiterated | Needham | Buy |
| Oct-30-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta Inc (AZTA) Stock Up 4.0% and Still Undervalued -- GF Scor - GuruFocus
Bank Watch: Is Azenta Inc stock suitable for long term investingSwing Trade & Weekly Chart Analysis and Guides - baoquankhu1.vn
Should Azenta’s (AZTA) New Multiomics President Reshape Confidence in Its Long-Term Genomics Strategy? - simplywall.st
Fund Flows: Can Azenta Inc sustain earnings growth2026 News Drivers & Daily Profit Focused Screening - baoquankhu1.vn
Guidance Update: Is Azenta Inc stock trending bullish2026 News Drivers & AI Driven Stock Movement Reports - baoquankhu1.vn
AZTA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Precision Trading with Azenta Inc. (AZTA) Risk Zones - Stock Traders Daily
Azenta names Trey Martin president of Multiomics business By Investing.com - Investing.com Australia
Azenta, Inc. Announces Executive Changes - marketscreener.com
Azenta names Trey Martin president of Multiomics business - Investing.com
Azenta Inc (AZTA) Shares Gap Down to $21.465 on Apr 7 - GuruFocus
Azenta, Inc. Executive Employment and Consulting Agreements: Key Terms, Non-Compete, and Intellectual Property Provisions (2026) - Minichart
Azenta Reshapes Multiomics Leadership and Executive Compensation - TipRanks
Trey Martin to lead Azenta (Nasdaq: AZTA) Multiomics growth push - Stock Titan
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution - PR Newswire
AZTA.O PE Ratio & Valuation, Is AZTA.O Overvalued - Intellectia AI
Aug Technicals: What is the dividend yield of Azenta IncWeekly Loss Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Market Moves: Is Azenta Inc showing insider buyingPortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn
Azenta Inc To Host Investor Day Transcript - GuruFocus
AZTA Technical Analysis & Stock Price Forecast - intellectia.ai
Azenta acquires UK Biocentre for £20.5 million - Investing.com
Azenta says Thelema has not secured financing deal did not close by March 31, 2026SEC filing - marketscreener.com
Azenta Inc (AZTA) Shares Up 2.83% on Apr 2 - GuruFocus
Azenta Faces Delay in B Medical Systems Divestiture - TipRanks
Travel Stocks: Will Azenta Inc benefit from rising consumer demandM&A Rumor & Consistent Profit Trading Strategies - baoquankhu1.vn
Azenta sale of B Medical Systems delayed as buyer fails to secure financing - TradingView
Azenta (NASDAQ: AZTA) faces delay in B Medical Systems sale as buyer financing lags - Stock Titan
Azenta Inc (BA3.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Allspring Global Investments Holdings LLC Raises Position in Azenta, Inc. $AZTA - MarketBeat
Azenta’s $63M B Medical Sale: A Critical March 31 Cutoff with Capital Distribution on the Line - Bitget
Azenta, Inc. (A2ZT34.SA) stock major holders - Yahoo Finance UK
Azenta (NASDAQ:AZTA) Shares Gap UpStill a Buy? - MarketBeat
Azenta Inc (AZTA) Stock Price Quote Today & Current Price Chart - Capital.com
Resistance Check: Is Azenta Inc showing insider buyingRate Cut & AI Enhanced Trading Alerts - baoquankhu1.vn
Aug Chart Watch: Is Azenta Inc stock trending bullishMarket Volume Report & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Assenagon Asset Management S.A. Increases Stock Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta (NASDAQ:AZTA) Sets New 52-Week LowHere's Why - MarketBeat
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know - Yahoo Finance
Azenta, Inc. (NASDAQ:AZTA) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Azenta divests B Medical Systems to streamline portfolio - MSN
Vanguard realigns reporting; subsidiaries to report AZTA holdings separately (AZTA) - Stock Titan
Azenta: Life Science Player Fails To Come To Life (NASDAQ:AZTA) - Seeking Alpha
Congress Asset Management Co. Invests $42.76 Million in Azenta, Inc. $AZTA - MarketBeat
Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
Contrasting Azenta (NASDAQ:AZTA) & Talkspace (NASDAQ:TALK) - Defense World
Trading Recap: Is Azenta Inc stock trending bullishForecast Cut & Free Reliable Trade Execution Plans - baoquankhu1.vn
Needham reiterates Azenta stock rating citing growth drivers By Investing.com - Investing.com Australia
Azenta's (AZTA) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Needham reiterates Azenta stock rating citing growth drivers - Investing.com
Needham Reiterates Buy Rating on Azenta (AZTA) with Price Target of $44 | AZTA Stock News - GuruFocus
Azenta (NASDAQ:AZTA) Hits New 1-Year LowHere's What Happened - MarketBeat
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):